Off-patent Drugs Bill
A Bill to require the Secretary of State to take steps to secure licences for off-patent drugs in new indications; to require the National Institute for Health and Care Excellence to conduct technology appraisals for off-patent drugs in new indications; and for connected purposes.
Legislative progress
Commons
2 Jul 2014
1st reading
Commons
7 Nov 2014
2nd reading
Bill documents
-
Bill Commons 29 Oct 2014Bill 22 2014-2015, as introduced
Chamber debates
-
Hansard 6 Nov 2015
-
Hansard 7 Nov 2014